Elucidation of the critical component of exosomes that confers protective effects to AECIIs via the PI3K/Akt/mTOR/Ki67 pathway will be the focus of future research, which could potentially advance BPD clinical therapy. Here, AKT1 is linked to bronchopulmonary dysplasia.